Our Clients
www.fundamentaltechnologiesii.com
Fundamental Technologies II (FTII) is a corporation that allows investors to participate in the returns from a portfolio of actively managed, synergistic investments in emerging technology companies. FTII offers accredited investors a way to participate in this exciting asset class, with excellent information flow, diversification, active management and very low costs.
GreenAngel Energy Corp. is a green energy technology company [whose] focus is commercializing new technologies that produce renewable energy, improve energy efficiency, or use renewable energy resources such as water, wind and solar. [Greenangel Energy Corp.] seek[s] companies that deploy or manage technologies and processes that reduce greenhouse gas (GHG) emissions. [Their] approach provides shareholders with the opportunity to invest in green energy companies at very early stages when valuations are low, with the objective of providing substantial financial gains. [Greenangel Energy Corp.] is always seeking promising companies to invest in and work with.
Med BioGene Inc. (MBI: TSX Venture) is a life science company focused on the development and commercialization of genomic-based clinical laboratory diagnostic and screening tests for cancer and cardiovascular disease. MBI’s lead products are LungExpress Dx™, a gene expression-based prognostic test for lung cancer, and LymphExpress Dx™, a gene expression-based diagnostic and prognostic test for lymphoma.
Other firms engage in a wide range of financial transactions including financings and restructurings. They might work for buyers or sellers. The only thing Strategic Exits does is work with shareholders to get the best price and terms when they sell their companies.
Vancouver Angel Technology Network
VANTEC Angels are accomplished Vancouver area technology entrepreneurs who wish to make early stage investments in, and sometimes provide mentoring or advice to, new companies.